Biotech

Centauri Therapeutics Secures $5.1M Boost from CARB-X to Advance Novel Antimicrobial into Clinical Trials

The funding will help complete non-clinical safety and efficacy studies, setting up ABX-01 for a first-in-human clinical trial planned for early 2026.

Qureight Analysis Supports Efficacy of Insilico Medicine’s AI-Discovered IPF Drug, Rentosertib, in Phase IIa Trial

Qureight’s AI-powered analysis of Insilico Medicine’s Phase IIa trial data for the novel IPF drug rentosertib supports its preliminary efficacy and underpins plans for expanded global clinical trials.

SPT Labtech and Semarion Join Forces to Advance Automated Cell-Based Assays

SPT Labtech and Semarion have partnered to create flexible, automated, and miniaturized workflows for advanced cell-based assays.

Shift Bioscience Unveils Improved Virtual Cell Model Ranking to Accelerate Gene Target Discovery

Shift Bioscience has unveiled an improved ranking system for virtual cell models, enhancing gene target discovery through better performance metrics in rejuvenation research.

Optibrium Joins Forces with TalTech to Develop Sustainable AI-Driven Drug Discovery

EU-funded PhD research program focuses on improving methods for predicting drug metabolism.

Enhanced Genomics and ALBORADA Drug Discovery Institute Accelerate Alzheimer’s Drug Discovery

Revolutionary 3D multi-omics platform reveals new therapeutic targets, promising faster, more successful drug development.